Chao Zhang

Chao Zhang currently serves as a member of the Scientific Advisory Board and Chief Scientific Officer at Iambic Therapeutics since July 2022. Prior to this role, Chao Zhang held multiple leadership positions at Plexxikon Inc. from December 2001 to June 2022, including Chief Executive Officer and Chief Scientific Officer, as well as Senior Vice President of Research. Chao Zhang's career began at Incyte as a Research Scientist from August 2000 to December 2001. Academically, Chao Zhang completed a postdoctoral fellowship in Structural & Systems Biology at the University of California, Berkeley, and earned a Ph.D. in Biomedical Engineering from Boston University, following a Bachelor of Science in Electrical Engineering from the University of Science and Technology of China.